Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
33.05 EUR | +2.96% | +2.32% | +17.41% |
Apr. 18 | Pharming Group to Issue EUR100 Million Convertible Bonds, Repurchase EUR125 Million Bonds | MT |
Mar. 07 | Van Lanschot Kempen Plans Early Redemption of EUR100 Million Notes | MT |
Strengths
- The group's high margin levels account for strong profits.
- The company is one of the best yield companies with high dividend expectations.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Investment Management & Fund Operators
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+17.41% | 1.49B | B- | ||
+4.75% | 8.74B | B+ | ||
+13.83% | 3.48B | C- | ||
-36.31% | 2.96B | B | ||
+13.29% | 2.52B | B- | ||
+14.51% | 2.39B | C | ||
+42.63% | 2.17B | - | - | |
+12.44% | 1.49B | B | ||
+9.13% | 1.42B | B+ | ||
0.00% | 1.02B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- VLK Stock
- Ratings Van Lanschot Kempen N.V